Diagnos Laboratorium Utama Tbk. vs Andalan Perkasa Abadi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Andalan Perkasa Abadi Tbk. trades at Rp31 (market cap 341.15B, 288.8K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Andalan Perkasa Abadi Tbk. are close in size by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 288.8K). Which is the better fit depends on your goals.
| DGNS | NASA | |
|---|---|---|
Market Cap | 310.75B | 341.15B |
Volume | 963.6K | 288.8K |
Lot | 9.64K | 2.89K |
Turnover | 217.67M | 9.16M |
Average Price | 225.89 | 31.73 |
Value | 217.67M | 9.16M |
Indicative Equilibrium Price | 226 | 31 |
Indicative Equilibrium Volume | 1K | 1.5K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Ayana Land International Tbk (the Company) was established under the name of PT Gatra Wibawa Sejati Based on Deed No. 157 dated February 27, 2014 of Humberg Lie, S.H., S.E., M.Kn., Notaryin Jakarta.
Read more on NASA →